

Pharmacy Podcast Network
Pharmacy Podcast Network
Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care.
Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.
PPN is a division of RxPR, LLC.
Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.
PPN is a division of RxPR, LLC.
Episodes
Mentioned books

Jan 28, 2025 • 49min
Key Factors Impacting MolDX® Coverage Determinations and Reimbursement with Dr. Megan Landsverk, Scientific Director, MolDX® and Chief Science Officer, Palmetto GBA® | Precision Health and PGx
Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, CEO of inGENEious RX Incorporated Pharmacogenomics Consulting, and Dr. Megan Landsverk, Scientific Director of MolDX® and Chief Science Officer of Palmetto GBA®, discuss how laboratories may overcome the challenges they face earning MolDX® coverage and reimbursement for their clinical pharmacogenomics tests. Specific to coverage determinations, the PGx veterans discuss test design, post-genotype translations, and technical assessments. Specific to reimbursement, the duo discusses evidence-based reporting and complete claim submissions. Also discussed is the importance of labs clearly defining intended use populations for tests and academic partnerships importance when labs develop and validate panels including drug-gene pairs the Clinical Pharmacogenetics Implementation Consortium and the United States Food and Drug Administration does not recognize as clinically utile for managing medications. Dr. Megan Landsverk is a Science Officer for Palmetto GBA, a Medicare Administrative Contractor (MAC) and a Science Director for the Molecular Diagnostic Services (MolDX) program developed to identify and establish coverage and reimbursement for molecular diagnostic services on behalf of Medicare. Dr. Landsverk received her PhD in Biochemistry and Molecular Biology from Baylor College of Medicine and postdoctoral training in Medical Genetics at the University of Washington. She is a board-certified Molecular Geneticist, completing her molecular genetics fellowship at Baylor College of Medicine. She has held multiple academic faculty positions and has numerous publications in the field of genetics. Prior to joining Palmetto, she served as a clinical laboratory director in academic, hospital, and commercial clinical laboratories and has experience in several genetic specialties including rare disease (pediatric and adult), cancer (somatic and inherited), and pharmacogenetics.

Jan 27, 2025 • 50min
PBM Strategies for the State of Arizona | PBM Reform
Interview with the new CEO of the Arizona Pharmacy Association, Garet Turner

Jan 25, 2025 • 56min
The Trump Card, Public Relations, and RxTeach | TWIRx
The Trump Card, Public Relations, and RxTeach | TWIRx
On this episode of TWIRx, what's the Trump Card going to do to Pharmacy Care?
How can a new strategy in Public Relations improve pharmacy?
FEATURED INTERVIEW:
Teaching innovators, RxTeach and the opportunity for Pharmacists
TWIRx News:
What Trump's first day orders mean for healthcare: Ditched drug models, pauses on rules and hiring By Fierce Healthcare Staff, Dave Muoio, Noah Tong, Emma Beavins, Anastassia Gliadkovskaya Jan 21, 2025 1:00pm
LINK: https://www.fiercehealthcare.com/regulatory/what-trumps-first-day-orders-mean-healthcare-ditched-drug-models-pauses-rules-and-hiring
More Bad News for Pharmacy Benefit Managers – AMAC Action Weekly Advocacy Update Posted on Friday, January 24, 2025 | by AMAC Action
LINK: https://amac.us/newsline/advocacy/more-bad-news-for-pharmacy-benefit-managers-amac-action-weekly-advocacy-update/
Managing Sustainable Drug Spend: 5 Trends Reshaping Pharmacy Benefits in 2025
https://www.pharmacytimes.com/view/managing-sustainable-drug-spend-5-trends-reshaping-pharmacy-benefits-in-2025
PQA Releases Report to Define Quality Medication Use for Rare Diseases
https://www.pharmacytimes.com/view/pqa-releases-report-to-define-quality-medication-use-for-rare-diseases
Best 80 Pharma Podcasts Awards 2025
Pharmacy Podcast Network is ranked # 1 Number One
from Million Podcasts:
https://www.millionpodcasts.com/pharma-podcasts/
This episode is sponsored by Independent Pharmacy Cooperative (IPC) and PrimeRx.
Losing the Reimbursement Battle? Win the War with a Smarter Pharmacy Purchasing Strategy
https://www.primerx.io/blog/primerx-market/losing-the-reimbursement-battle-win-the-war-with-a-smarter-pharmacy-purchasing-strategy/

Jan 23, 2025 • 16min
Branding: A Driver for Success | Marketing Vitals - On the Pulse of Healthcare
One of the biggest drivers in your business’s overall success is branding. Your brand is your pharmacy’s unique identity that distinguishes you from your competitors. It’s more than just your logo. It’s your business’s values, credibility, and customer experience. On this episode, Nicolle and Kelly dive into how to use your branding to stand out from the crowd and make a strong, lasting impression.

Jan 22, 2025 • 1h 11min
Leadership, Neuroscience, and Running a Pharmacy | TWIRx
On This Week in Pharmacy, we talk about the latest news:
From Reuters:
US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain
From Pharmacy Times:
The Evolving Business Model of Pharmacy: Moving Beyond Dispensing
From USA Today:
Walgreens turnaround continues with 450 stores to be closed this year
Dr. Adam Robinson, PharmD poses a great question:
Who am I as a leader? Am I leading correctly? Why am I so stressed?
These are questions as pharmacist and owners we ask ourselves frequently. Terri and Kelley can help unpack these deep question and give us insight into how a leaders brain works and some simple tools to move the needle forward.
Thanks to PrimeRx for your support of todays TWIRx
Register for PrimeRx MARKET membership is Free
Shop smarter and make purchases totaling just 500 in generics by Jan 31,2025,
Enjoy and amazon gift card.
https://landing.primerx.io/holidaypromo

Jan 21, 2025 • 29min
Unpacking PBMs with Benjamin Jolley | CPhT Connect
Mike Johnston, CEO of NPTA, Ashleigh Smith, NPTA- Director of Continuing Education, Benjamin Jolley, PharmD

Jan 20, 2025 • 35min
Exploring Non-Stimulant ADHD Treatment Strategies with Dr Richard Price | Managing ADHD- A Lifelong Challenge
Rabbi Richard Louis Price, M.D. is a Yale & Columbia University-trained psychiatry professor at Weill Cornell Medical College/New York-Presbyterian Hospital. Over the past two decades, he has evaluated over 20,000 patients serving as a medical director at Achieve Behavioral Health in Monsey; Rockland TMS & Wellness Center; Hamaspik of Orange and Rockland Counties; Volunteer Counseling Services in New City; ParCare in Brooklyn, Chai Urgent Care Centers of New York, Pennsylvania, and Florida,, and has a private pediatric and adult psychotherapy and psychopharmacology practice in Monsey, New York. Dr. Price is triple board certified in Psychiatry, Consultation-Liaison/Mind-Body Medicine, and Addiction Medicine and has been awarded numerous patents in the United States, Canada, Europe, and Israel for a novel pharmacotherapy for the treatment of both core and associated symptoms of Autism Spectrum Disorder. Dr. Price has served on the advisory boards and as a national speaker for several pharmaceutical companies, such as Abbvie, Alkermes, Allergan, Almatica, Axsome, Idorsia, Intracellular, Janssen, Jazz, Lumbeck, Neuronetics, Otsuka, Supernus, and Vanda and has been recognized as a top Medical Educator by the American Psychiatric Association. He is also a professional singer and taekwondo black belt.
ADHD ARTICLE PUBLISHED: https://pmc.ncbi.nlm.nih.gov/articles/PMC10374479/
HISTORICAL OVERVIEW OF VILOXAZINE: https://pmc.ncbi.nlm.nih.gov/articles/PMC8219567/

Jan 17, 2025 • 23min
Pharmacists Code of Ethics | PEERx
Ethics in pharmacy is not just about following the law. It involves prioritizing our patients and understanding the ethical principles that pharmacists must follow. This podcast delves into a wide range of topics s designed to provide complimentary continuing education programming to honor the ethical principle of beneficence and equip pharmacists, pharmacy technicians, and student pharmacists with resources, skills, and knowledge to handle ethical dilemmas in your practice.

Jan 16, 2025 • 39min
Advantages of Levothyroxine Capsule Over Tablet | YARAL Pharma
Every year, millions of patients rely on Levothyroxine to manage their hypothyroidism, but it's important to note that not all Levothyroxine medications are the same. In today’s episode of the Pharmacy Podcast Network, we’ll explore the management of hypothyroidism and discuss how alternative dosage forms might be the solution for patients who struggle with traditional tablet formulations.
When it comes to the management of hypothyroidism, not all levothyroxine medications are created equal.
Stephen Beckman, CEO Yaral Pharma
Sonja O'Bryan, RPh

Jan 14, 2025 • 32min
Talking Integration to Build Healthier Communities and Specialty Pharmacies with PrimeRx | NASP Specialty Pharmacy Podcast
During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Ketan Mehta, the visionary CEO of PrimeRx. They explore how the advancement of technology has changed the landscape of specialty pharmacy and ways digital integration can help specialty pharmacies achieve a patient-centric holistic ecosystem.